Molecules 2013, 18
15048
References
1. Neto, B.A.D.; Lapis, A.A.M. Recent developments in the chemistry of desoxyribonucleic acid
(DNA) intercalators: Principles, design, synthesis, applications and trends. Molecules 2009, 14,
1725‒1746.
2. Mukherjee, A.; Lavery, R.; Bagchi, B.; Hynes, J.T. On the molecular mechanism of drug
intercalation into DNA: A simulation study of the intercalation pathway, free energy, and DNA
structural changes. J. Am. Chem. Soc. 2008, 130, 9747‒9755.
3. Hurley, H.L. DNA and its associated processes as targets for cancer therapy. Nat. Rev. Cancer
2002, 2, 188‒200.
4. Ihmels, H.; Otto, D. Intercalation of organic dye molecules into double-stranded DNA general
principles and recent developments. Top. Curr. Chem. 2005, 258, 161‒204.
5. Barros, F.W.A.; Silva, T.G.; Pitta, M.G.R.; Bezerra, D.P.; Costa-Lotufo, L.V.; Moraes, M.O.;
Pessoa, C.; Moura, M.A.F.B.; Abreu, F.C.; Lima, M.C.A.; et al. Synthesis and cytotoxic activity
of new acridine-thiazolidine derivatives. Bioorg. Med. Chem. 2012, 20, 3533‒3539.
6. Ghosh, R.; Bhowik, S.; Bagchi, A.; Das, D.; Ghosh, S. Chemotherapeutic potential of 9-phenyl
acridine: Biophysical studies on its binding to DNA. Eur. Biophys. J. 2010, 39, 1243‒1249.
7. Gao, C.; Liu, F.; Luan, X.; Tan, C.; Liu, H.; Xie, Y.; Jin, Y.; Jiang, Y. Novel synthetic
2-amino-10-(3,5-dimethoxy)benzyl-9(10H)-acridinone derivatives as potent DNA-binding
antiproliferative agents. Bioorg. Med. Chem. 2010, 18, 7507‒7514.
8. Janovec, L.; Kozurkova, M.; Sabolova, D.; Ungvarsky, J.; Paulikova, H.; Plsikova, J.; Vantosa, Z.;
Imrich, J. Cytotoxic 3,6-bis((imidazolidionone)imino)acridines: Synthesis, DNA binding and
molecular modeling. Bioorg. Med. Chem. 2011, 19, 1790‒1801.
9. Liu, Q.; Zhang, J.; Wang, M.; Zhang, D.; Lu, Q.; Huang, Y.; Lin, H.; Yu, X. Synthesis, DNA
binding and cleavage activity of macrocyclic polyamines bearing mono- or bis-acridine moieties.
Eur. J. Med. Chem. 2010, 45, 5302‒5308.
10. Plsikova, J.; Janovec, L.; Koval, J.; Ungvarsky, J.; Mikes, J.; Jendzelovsky, R.; Fedorocko, P.;
Imrich, J.; Kristian, P.; Kasparkova, J.; et al. 3,6-Bis(3-alkyl-guanidino)acridines as DNA-
intercalating antitumor agents. Eur. J. Med. Chem. 2012, 57, 283‒295.
11. Pommier, Y. Drugging Topoisomerases: Lessons and Challenges. ACS Chem. Biol. 2013, 8,
82−95.
12. Pommier, Y. DNA topoisomerase I inhibitors: Chemistry, biology and interfacial inhibition.
Chem. Rev. 2009, 109, 2894‒2902.
13. Wang, Y.-C.; Qiana, C.; Penga, Z.-L.; Hou, X.-J.; Wang, L.-L.; Chaoa, H.; Ji, L.-N.
Dual topoisomerase
I
and II poisoning by chiral Ru(II) complexes containing
2-thiophenylimidazo[4,5-f][1,10]phenanthroline derivatives. J. Inorg. Biochem. 2014, 130, 15–27.
14. Jangir, D.K.; Dey, S.K.; Kundu, S. Mehrotra, R. Assessment of amsacrine binding with DNA
using UV-visible, circular dichroism and Raman spectroscopic techniques. J. Photochem.
Photobiol. B 2012, 114, 38‒43.
15. Sanchez, I.; Reches, R.; Caignard, D.H.; Renard, P.; Pujol, M.D. Synthesis and biological
evaluation of modified acridines: The effect of N- and O-substituent in the nitrogenated ring on
antitumor activity. Eur. J. Med. Chem. 2006, 41, 340‒352.